AYTU BIOPHARMA, INC - FORM 10-Q - EX-32.1 - CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE - February 14, 2020

Attached files

file filename
EX-31.2 - CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF - AYTU BIOPHARMA, INCaytu_ex312.htm
EX-31.1 - CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF - AYTU BIOPHARMA, INCaytu_ex311.htm
10-Q - QUARTERLY REPORT - AYTU BIOPHARMA, INCaytu_10q.htm
 
 
Exhibit 32.1
 
AYTU BIOSCIENCE, INC.
 
Certification Pursuant to 18 U.S.C. Section 1350, as Adopted
 
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
 
In connection with the filing of the quarterly report on Form 10-Q for the quarter ended December 31, 2019 (the “Report”) by Aytu BioScience, Inc. (the “Company”), each of the undersigned hereby certifies that:
 
1. 
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and
 
2. 
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
 
 
 
 
 
 
 
Date: February 14, 2020
By:  
/s/ Joshua R. Disbrow  
 
 
 
Joshua R. Disbrow  
 
 
 
Chief Executive Officer (principal executive officer)
 
 
 
 
 
 
 
 
Date: February 14, 2020
By:  
/s/ David A. Green
 
 
 
 David A. Green
 
 
 
Chief Financial Officer (principal financial and accounting officer) 
 
 
 
 

Stock widget

Investing forum

AYTU BIOPHARMA, INC Reports